The American Heart Association’s (AHA) Scientific Sessions 2025 begin today in New Orleans, Louisiana, and the Cardiology Advisor team is excited to bring to our readers the latest research and ...

In a new study, prolonged use of melatonin as a sleep aid in patients with insomnia was associated with increased risk for ...

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

New research says the popular sleep aid melatonin may negatively impact the heart — but experts caution that more research is ...

New research has raised concerns about the long-term use of melatonin supplements, which are widely available for purchase in ...

A study links long-term melatonin use to increased heart failure risk and hospitalization. The findings were presented at American Heart Association's Scientific Sessions 2025. Researchers didn't ...

Presentations reveal new insights on heart health, including inflammation, MINOCA, kidney function, and maternal outcomes.

New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant ...

A five-year review of over 130,000 adults with insomnia found that long-term melatonin use was linked to a higher risk of heart failure and death, prompting researchers to call for further study into ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...

Sacubitril/valsartan significantly reduced cardiomyopathy risk in patients undergoing anthracycline chemotherapy, but further research is needed for broader applicability. Muvalaplin, an oral drug, ...

The scientific sessions began with a CME-cum-workshop on critical care and disaster management, where experts underscored the ...